In 2003, it was shown for the first time that in EAE, the central nervous system (CNS) has an expansion of an IL-17-producing T-cell population [32] capable of developing autoimmunity during adaptive transfer [33], and IL-23 is necessary for stabilizing their functions [34]. Here, IL17A is linked to Autoimmunity.